Other Species / Isoforms
  N-Myc (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T58-p
KKFELLPtPPLsPsr
Upstream
Downstream
5 38
N-Myc (human)
T58-p
N-Myc (mouse)
T58-p
N-Myc (rat)
T58-p
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • protein degradation
  • ubiquitination
Putative in vivo kinases:
  • GSK3B (human)
Regulatory protein:
  • N-Myc (human)
Treatment
  • angiotensin_2
  • BIO
  • HA1077
  • LY294002
  • MG132
  • nocodazole
  • selumetinib
  • siRNA
  • vemurafenib
N-Myc (human) KKFELLPtPPLsPsr T58-p
N-Myc (mouse) KKFELLPtPPLsPsR T58-p
N-Myc (rat) KKFELLPtPPLSPSR T58-p
S62-p
LLPtPPLsPsrGFAE
Upstream
Downstream
4 32
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • protein degradation
  • protein stabilization
  • ubiquitination
Putative in vivo kinases:
  • mTOR (human)
Treatment
  • LY294002
  • MG132
  • nocodazole
  • selumetinib
  • siRNA
  • Torin1
  • vemurafenib
N-Myc (human) LLPtPPLsPsrGFAE S62-p
N-Myc (mouse) LLPtPPLsPsRAFPE S62-p
N-Myc (rat) LLPtPPLSPSRAFPE S62
S64-p
PtPPLsPsrGFAEHS
0 6
N-Myc (human) PtPPLsPsrGFAEHS S64-p
N-Myc (mouse) PtPPLsPsRAFPEHS S64-p
N-Myc (rat) PtPPLSPSRAFPEHS S64
R65-me
tPPLsPsrGFAEHSS
Downstream
1 0
Effects on Modified Protein
  • protein stabilization
N-Myc (human) tPPLsPsrGFAEHSS R65-me
N-Myc (mouse) tPPLsPsRAFPEHSP R65
N-Myc (rat) tPPLSPSRAFPEHSP R65
K133-ac
LERAVSEkLQHGRGP
0 1
N-Myc (human) LERAVSEkLQHGRGP K133-ac
N-Myc (mouse) LERAVNEKLQHGHGP K134
N-Myc (rat) LERAVNEKLQHGHGP K134
K133
LERAVSEKLQHGRGP
0 1
N-Myc (human) LERAVSEKLQHGRGP K133
N-Myc (mouse) LERAVNEkLQHGHGP K134-ub
N-Myc (rat) LERAVNEKLQHGHGP K134
S156-p
SPGAGAAsPAGRGHG
0 4
N-Myc (human) SPGAGAAsPAGRGHG S156-p
N-Myc (mouse) APGVGASsPGGRALG S157-p
N-Myc (rat) APGVGASSSGGRALG S157
R238-m2
APGVAPPrPGGrQTS
0 1
N-Myc (human) APGVAPPrPGGrQTS R238-m2
N-Myc (mouse) APVAAPARAGGRPAS R236
N-Myc (rat) APVAAPARGSGRPAN R236
R242-m2
APPrPGGrQTSGGDH
0 1
N-Myc (human) APPrPGGrQTSGGDH R242-m2
N-Myc (mouse) APARAGGRPASSGEA R240
N-Myc (rat) APARGSGRPANSGEH R240
S261-p
TSGEDTLsDsDDEDD
Upstream
1 0
Kinase, in vitro:
  • CK2A1 (human)
N-Myc (human) TSGEDTLsDsDDEDD S261-p
N-Myc (mouse) TSGEDTLSDSDDEDD S259
N-Myc (rat) TSGEDTLSDSDDEDD S259
S263-p
GEDTLsDsDDEDDEE
Upstream
1 0
Kinase, in vitro:
  • CK2A1 (human)
N-Myc (human) GEDTLsDsDDEDDEE S263-p
N-Myc (mouse) GEDTLSDSDDEDDEE S261
N-Myc (rat) GEDTLSDSDDEDDEE S261
K321-ub
QSSELILkRCLPIHQ
0 1
N-Myc (human) QSSELILkRCLPIHQ K321-ub
N-Myc (mouse) QPGELILKRCVPIHQ K319
N-Myc (rat) QPGELILKRCVPIHQ K319
S355-p
KKIKSEAsPRPLKSV
0 3
N-Myc (human) KKIKSEAsPRPLKSV S355-p
N-Myc (mouse) KKIKSEAsPRPLKSV S353-p
N-Myc (rat) KKIKSEASPRPLKSV S353